PHI with Ureteral stones
How does this condition affect your private health insurance?
Harnleitersteine (Ureteral stones) are solid masses, typically kidney stones, that have moved from the kidney into the ureter, the tube connecting the kidney to the bladder. This movement often causes excruciating pain, known as renal colic, due to obstruction and spasm of the ureter. Symptoms include severe flank pain radiating to the groin, nausea, vomiting, hematuria (blood in urine), and frequent urge to urinate. They form from crystallized minerals like calcium oxalate or uric acid. Treatment ranges from conservative management (pain relief, hydration for small stones) to medical expulsive therapy, lithotripsy, or surgical removal for larger, obstructing stones. Complications can include infection or kidney damage.
PKV Risk Assessment
However, some specialized PHI providers may insure you with a surcharge of up to 15%.
Impact on Your Insurance Policy
Duration of Illness (Initial)
Hours to several days for an acute episode of renal colic until the stone passes or is removed.
Duration of Illness (Lifetime)
Often a one-time event, but recurrence is common, with approximately 50% of patients experiencing another stone within 5-10 years. Can be recurrent or chronic for predisposed individuals.
Cost of Treatment (Initial)
Ranges from a few hundred dollars for conservative management (e.g., emergency visit, pain medication) to several thousand dollars (e.g., $5,000 - $20,000+) for procedures like lithotripsy or ureteroscopy, depending on the healthcare system and complexity.
Cost of Treatment (Lifetime)
Can be substantial if recurrent, potentially involving multiple procedures, diagnostic tests, and long-term preventive management, easily accumulating tens of thousands of dollars over a lifetime for some individuals.
Mortality Rate
Very low, typically less than 0.1%, primarily in cases of severe, untreated urosepsis resulting from an obstructed and infected kidney.
Risk of Secondary Damages
Moderate (10-20%) if not promptly managed, including risk of kidney damage (hydronephrosis), infection (pyelonephritis, urosepsis), and rarely, ureteral stricture or chronic pain.
Probability of Full Recovery
High (over 90%) after successful stone passage or removal, with resolution of acute symptoms and organ function returning to normal, though the risk of future stones remains.
Underlying Disease Risk
Moderate (20-50%). Often associated with underlying metabolic disorders (e.g., hypercalciuria, hyperoxaluria, hyperuricosuria, primary hyperparathyroidism), recurrent urinary tract infections, certain medications, and genetic predispositions.